Such forward-looking statements are subject to certainrisks and uncertainties, which could cause actual results or outcomes to differmaterially from those currently anticipated. Shareholders, potential investors and otherreaders are urged to consider these factors in evaluating the forward-lookingstatements and are cautioned not to place undue reliance on such forward-lookingstatements. The forward-looking statements included herein are only made as ofthe date of this press release and the Company undertakes no obligation topublicly update such forward-looking statements to reflect subsequent events orcircumstances.JOHNSON OUTDOORS INC. * RadNet reports Revenue of $128.0 million and Adjusted EBITDA(1) of $26.3 million; increases of 12.4% and 19.4%, respectively over the prior year’s quarterly results * Overall procedure volumes increased 9.3% * Per share loss was $(0.02) compared to $(0.15) for three month period ended March 31, 2008 * RadNet reaffirms its previously announced 2009 Guidance of $515-545 million of Revenue and $105-$115 of Adjusted EBITDA(1)LOS ANGELES, May 8, 2009 (GLOBE NEWSWIRE) — RadNet, Inc.

(Nasdaq:RDNT), anational leader in providing high-quality, cost-effective diagnostic imagingservices through a network of fully-owned and operated outpatient imagingcenters, today reported financial results for its first quarter ended March 31,2009.RadNet reported Revenue and Adjusted EBITDA(1) of $128.0 million and $26.3million, respectively. Revenue increased 12.4% (or $14.1 million) and AdjustedEBITDA(1) increased 19.4% (or $4.3 million), respectively, over the prior year’squarter. The results reflect improved procedural volume in existing centers aswell as the contribution of acquisitions and operating initiatives.For the first quarter of 2009, as compared to the prior year’s quarter, MRIvolume increased 14.8%, CT volume increased 12.4% and PET/CT volume increased1.4%. Overall volume, taking into account routine imaging exams, inclusive ofx-ray, ultrasound, mammography and other exams, increased 9.3% over the prioryear’s quarter.On a same-center basis, including only those centers which were part of RadNetfor both the first quarters of 2009 and 2008, MRI volume increased 5.7%, CTvolume increased 5.6% and PET/CT volume increased 1.0%. Overall same-centervolume, taking into account routine imaging exams, inclusive of x-ray,ultrasound, mammography and other exams, increased 2.8% over the prior year’squarter.Net Loss for the first quarter of 2009 was $842,000, or $(0.02) per share,compared to a net loss of $5.5 million or $(0.15) per share, reported for thethree month period ended March 31, 2008 (based upon a weighted average number ofshares outstanding of 35.9 million and 35.6 million for these periods in 2009and 2008, respectively). Affecting net income in the first quarter of 2009 werecertain non-cash expenses including: * $1.1 million non-cash loss on the fair value adjustments of interest rate swaps related to the Company’s credit facilities; * $670,000 of Deferred Financing Expense related to the amortization of financing fees paid as part of the Company’s $405 million credit facilities drawn down in November 2006 in connection with the Radiologix acquisition and the incremental term loans and revolving credit facility arranged in August 2007 and February 2008; and * $709,000 of non-cash employee stock compensation expense resulting from the vesting of certain options and warrants.”We are pleased with our progress in the first quarter of 2009.

In particular,we noted an increase in our EBITDA margins to 20.6% from our full-year 2008margin of 19.6%. We are encouraged that some of our more recent operational andcost savings initiatives are beginning to pay dividends, as evidenced by asignificant improvement in our bottom-line performance. We continue to seestrong volumes in our markets and have yet to see a material negative impact onour business from the broader national economic troubles,” said Dr. HowardBerger, Chairman and Chief Executive Officer of RadNet.”We are also pleased that in the first quarter of 2009, we reduced our AccountsPayable and Accrued Expenses by almost $10 million, and improved our workingcapital position by almost $5 million. Even taking this into consideration, ourcash flow from operations this quarter was $19.4 million greater than thecorresponding period last year. Because much of our capital needs for the yearwill have been satisfied by the end of the second quarter, we expect free cashflow in the second half of the year to exceed $25 million,” continued Dr.Berger.Dr.